X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2579) 2579
Publication (485) 485
Book Review (13) 13
Book Chapter (10) 10
Conference Proceeding (7) 7
Book / eBook (1) 1
Data Set (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1939) 1939
bortezomib (1715) 1715
index medicus (1575) 1575
boronic acids - pharmacology (1398) 1398
pyrazines - pharmacology (1145) 1145
animals (890) 890
cell line, tumor (697) 697
oncology (672) 672
antineoplastic agents - pharmacology (622) 622
apoptosis - drug effects (582) 582
apoptosis (578) 578
mice (517) 517
proteasome inhibitors (504) 504
boronic acids - therapeutic use (484) 484
boronic acids - chemistry (463) 463
pyrazines - therapeutic use (461) 461
female (459) 459
male (456) 456
cancer (398) 398
proteasome endopeptidase complex - metabolism (389) 389
hematology (387) 387
multiple myeloma - drug therapy (385) 385
biochemistry & molecular biology (368) 368
protease inhibitors - pharmacology (324) 324
boronic acids - administration & dosage (317) 317
multiple myeloma (316) 316
pyrazines - administration & dosage (291) 291
multiple-myeloma (290) 290
antineoplastic agents - therapeutic use (284) 284
nf-kappa-b (262) 262
article (256) 256
drug synergism (256) 256
cell proliferation - drug effects (253) 253
nf-kappa b - metabolism (250) 250
multiple myeloma - metabolism (246) 246
middle aged (236) 236
proteins (227) 227
research (220) 220
activation (218) 218
multiple myeloma - pathology (216) 216
expression (206) 206
cell biology (202) 202
aged (191) 191
boronic acids (188) 188
dose-response relationship, drug (188) 188
boronic acids - metabolism (181) 181
pharmacology & pharmacy (181) 181
blotting, western (179) 179
analysis (174) 174
proteasome (171) 171
proteasome inhibitor (166) 166
hemic and lymphatic diseases (165) 165
tumor cells, cultured (162) 162
cell survival - drug effects (161) 161
adult (159) 159
boronic acid (158) 158
antineoplastic combined chemotherapy protocols - therapeutic use (156) 156
proteasome inhibitors - pharmacology (153) 153
proteasome inhibitor bortezomib (152) 152
enzyme inhibitors - pharmacology (151) 151
protease inhibitors - therapeutic use (151) 151
treatment outcome (149) 149
signal transduction - drug effects (148) 148
in-vivo (146) 146
therapy (146) 146
drug resistance, neoplasm (144) 144
chemistry, medicinal (143) 143
xenograft model antitumor assays (143) 143
cells (137) 137
cells, cultured (134) 134
phosphorylation (133) 133
rats (133) 133
resistance (133) 133
chemotherapy (131) 131
multiple-myeloma cells (131) 131
signal transduction (129) 129
in-vitro (128) 128
chemistry, multidisciplinary (122) 122
induced apoptosis (121) 121
time factors (120) 120
health aspects (118) 118
care and treatment (117) 117
cell line (116) 116
kinetics (116) 116
growth (114) 114
structure-activity relationship (113) 113
abridged index medicus (112) 112
boronic acids - adverse effects (111) 111
ps-341 (111) 111
binding (110) 110
flow cytometry (109) 109
neoplasms - drug therapy (109) 109
molecular structure (108) 108
pyrazines - adverse effects (108) 108
down-regulation (107) 107
pathway (107) 107
biology (105) 105
hydrogen-ion concentration (105) 105
antineoplastic combined chemotherapy protocols - pharmacology (102) 102
caspases - metabolism (102) 102
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2513) 2513
Chinese (48) 48
French (8) 8
Japanese (7) 7
Hungarian (2) 2
Polish (2) 2
Turkish (2) 2
Czech (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 09/2012, Volume 7, Issue 9, p. e46484
Journal Article
Journal of the American Chemical Society, ISSN 0002-7863, 04/2014, Volume 136, Issue 17, pp. 6203 - 6206
Journal Article
Chemical Communications, ISSN 1359-7345, 07/2014, Volume 50, Issue 56, pp. 7527 - 7530
A copper-mediated gem-difluoromethylenation of aryl, heteroaryl and vinyl boronic acids with bromodifluoromethylated oxazole or thiazole derivatives has been... 
BORONIC ACIDS | REAGENT | IODIDES | CROSS-COUPLING REACTIONS | PHOSPHONATES | FLUOROALKYLATION | ARYL | FLUORINATION | FACILE | CHEMISTRY, MULTIDISCIPLINARY | Copper - chemistry | Boronic Acids - metabolism | Copper - metabolism | Hydrocarbons, Fluorinated - chemistry | Hydrocarbons, Fluorinated - metabolism | Boronic Acids - chemistry | Methylation
Journal Article
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 4/2010, Volume 107, Issue 16, pp. 7257 - 7262
Journal Article
Journal of the American Chemical Society, ISSN 0002-7863, 10/2013, Volume 135, Issue 41, pp. 15501 - 15507
Journal Article
Journal of the American Chemical Society, ISSN 0002-7863, 01/2014, Volume 136, Issue 3, pp. 874 - 877
Journal Article
Journal of the American Chemical Society, ISSN 0002-7863, 04/2006, Volume 128, Issue 13, pp. 4226 - 4227
This study describes a new class of carbohydrate-binding boronic acids. ortho-Hydroxymethyl phenylboronic acid (boronophthalide) was shown to be superior to... 
OLIGOSACCHARIDES | MOLECULAR RECOGNITION | ESTERS | RECEPTOR | SENSORS | SELECTIVITY | CHEMISTRY, MULTIDISCIPLINARY | Boronic Acids - metabolism | Glycosides - metabolism | Solubility | Water - chemistry | Boronic Acids - chemistry | Kinetics | Glycosides - chemistry | Glycosides | Methyl groups | Chemical properties
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2013, Volume 8, Issue 2, p. e55705
Previously, we reported that cancerous inhibitor of protein phosphatase 2A (CIP2A) mediates the apoptotic effect of bortezomib in hepatocellular carcinoma... 
APOPTOSIS | CIP2A EXPRESSION | SIGNALING PATHWAY | POOR-PROGNOSIS | UBIQUITIN | MULTIDISCIPLINARY SCIENCES | PROSTATE-CANCER | TUMOR-SUPPRESSOR | PP2A | ENDOPLASMIC-RETICULUM STRESS | CELL-SURVIVAL | Phosphorylation | Autoantigens - metabolism | Bortezomib | Boronic Acids - metabolism | Protein Phosphatase 2 - antagonists & inhibitors | Humans | Pyrazines - metabolism | Autophagy - drug effects | Blotting, Western | Dose-Response Relationship, Drug | Gene Expression Regulation - drug effects | Flow Cytometry | Time Factors | Acridine Orange | Fluorescent Antibody Technique | Liver Neoplasms - metabolism | Protein Phosphatase 2 - metabolism | Cell Line, Tumor | Membrane Proteins - metabolism | Proteasome Endopeptidase Complex - metabolism | Pyrazines - pharmacology | Microscopy, Fluorescence | Boronic Acids - pharmacology | Carcinoma, Hepatocellular - metabolism | Phosphatases | Dosage and administration | Research | Hepatoma | Ubiquitin-proteasome system | Drug therapy | Veterinary colleges | Phosphoprotein phosphatase | Clinical trials | Hepatocellular carcinoma | AKT protein | Kinases | Phosphatase | Veterinary medicine | Cancer therapies | Autophagy | Proteins | Liver cancer | Cell growth | Cell cycle | Inhibition | Calyculin A | Medical research | Immunoglobulins | Studies | Inhibitors | Medical prognosis | Cell lines | Protein phosphatase | Endoplasmic reticulum | Prostate cancer | Phagocytosis | Tumors | Apoptosis
Journal Article